NeuroOne Medical Technologies Corp (NMTC)
0.781
-0.08
(-9.71%)
USD |
NASDAQ |
Nov 14, 16:00
0.79
+0.01
(+1.15%)
After-Hours: 20:00
NeuroOne Medical Technologies Research and Development Expense (Quarterly): 1.195M for June 30, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 1.195M |
| March 31, 2024 | 1.274M |
| December 31, 2023 | 1.483M |
| September 30, 2023 | 1.779M |
| June 30, 2023 | 1.892M |
| March 31, 2023 | 1.706M |
| December 31, 2022 | 1.564M |
| September 30, 2022 | 1.438M |
| June 30, 2022 | 1.225M |
| March 31, 2022 | 1.205M |
| December 31, 2021 | 1.060M |
| September 30, 2021 | 1.008M |
| June 30, 2021 | 0.9011M |
| March 31, 2021 | 1.081M |
| December 31, 2020 | 0.9342M |
| September 30, 2020 | 0.7847M |
| Date | Value |
|---|---|
| June 30, 2020 | 0.4472M |
| March 31, 2020 | 0.3421M |
| December 31, 2019 | 0.5018M |
| September 30, 2019 | 0.4609M |
| June 30, 2019 | 0.4228M |
| March 31, 2019 | 0.4363M |
| December 31, 2018 | 0.2092M |
| June 30, 2018 | 0.2255M |
| March 31, 2018 | 0.105M |
| December 31, 2017 | 0.2349M |
| September 30, 2017 | 0.2717M |
| June 30, 2017 | 0.1567M |
| March 31, 2017 | 0.072M |
| December 31, 2016 | |
| September 30, 2016 | 0.00 |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
0.3421M
Minimum
Mar 2020
1.892M
Maximum
Jun 2023
1.149M
Average
1.195M
Median
Jun 2024
Research and Development Expense (Quarterly) Benchmarks
| SINTX Technologies Inc | 1.677M |
| Nutriband Inc | 0.774M |
| enVVeno Medical Corp | 2.859M |
| Beyond Air Inc | 6.009M |
| CVRx Inc | 2.504M |